Phage Refinery Announces PureFage™ Service

Image of phage on bacteria

Phage Refinery is very excited to announce its PureFage™ Service, PureFage enables researchers and therapy development organizations to quickly and easily isolate and characterize phage for their target bacteria. Leveraging the technology and know-how from decades of world-class phage research, isolation can be performed on demand in days without the distraction and capital expense required

Phage Refinery Announces PureFage™ Service Read More »

Phage Refinery Joins ARPA-H Customer Experience Hub

ARPA-H Customer Experience Hub Logo

Phage Refinery has been selected to join the ARPA-H Customer Experience Hub (CX Hub). The CX Hub is part of ARPANET-H, and is a nationwide health innovation network of more than 300 of the leading healthcare entities spanning government and educational research, for-profit product and services firms, and clinical practitioners. The Advanced Research Projects Agency

Phage Refinery Joins ARPA-H Customer Experience Hub Read More »

Phage Therapy in the Press!

Lead photo for January 21, 2024 CNN article on phage therapy

On Sunday, January 21, 2024, CNN published an an informative article on the growing threat of Multi-Drug Resistant “superbug” bacterial infections, and the potential of phage therapy to combat this accelerating health crisis. The article includes some key observations from prominent phage researcher Dr. Dwayne Roach, professor at San Diego State University and member of

Phage Therapy in the Press! Read More »

Phage Refinery Joins UTSA New Venture Incubator

Phage Refinery has been accepted into the New Venture Incubator (NVI) at the University of Texas at San Antonio. The NVI program is focused on supporting the translation of research technology into commercialized products and services. The program is managed by Dr. Christine Burke, Director of the Office of Commercialization and Innovation, and will provide

Phage Refinery Joins UTSA New Venture Incubator Read More »

Research Published in Biophysica

Research results from Phage Refinery co-founders Dr Phil Serwer and Dr Jim Chambers was published September 27th, 2023 in Biophysica, an international, peer-reviewed, open access journal on applying the methods of physics, chemistry, and math to study biological systems. Along with colleagues Elena T. Wright and Barbara Hunter, their research demonstrates a safe means for preparing

Research Published in Biophysica Read More »

Founders Research Featured

Phage Refinery co-founders Dr. Phil Serwer and Dr. Jim Chambers had their recent research featured in a news article from the UT Health Science Center at San Antonio. Entitled “A naturally occurring alternative to antibiotics?“, it highlights their work in determining bacteriophage persistence as well as safely removing potential pathogens from phage samples. Their research

Founders Research Featured Read More »

Scroll to Top